Speaker: Andrew Singleton, PhD
Acting Director, Center for Alzheimer’s and Related Dementias, USA
Registration: available now on Eventbrite
Livestreaming via Vimeo: Vimeo
Abstract: We have succeeded in making tremendous progress in our understanding of the genetics of Parkinson’s disease over the last two decades. This work continues at a significant pace and, to a large extent, our current success is driven by collaborative, team-based research. Here I will describe our progress so far, particularly in the context of understanding risk in typical Parkinson’s disease. I will also discuss two ongoing initiatives led by our laboratory, the FOUNDIN-PD study and the Global Parkinson’s Genetics Program (GP2). The former is currently a pilot of a study that aims to produce foundational molecular insights into the pathogenesis of disease using iPS modeling at scale. The latter is a global initiative aimed at accelerating genetic discovery, diversifying the ancestral basis of this research, and democratizing the research process.
The Killam Seminar Series at The Neuro
Supported by the generosity of the Killam Trusts, The Neuro’s Killam Seminar series hosts outstanding guest speakers whose research is of interest to the scientific community at The Neuro and McGill University.
How to participate via Zoom:
1. You can either join a meeting via the invite link or the Meeting ID #.
2. If you click the link it will automatically bring you to the meeting. If you do not have the link and only the meeting ID go to the Zoom application and click “Join a meeting” where it will prompt you to input your name and the Meeting ID #.
3. Use the toolbar at the bottom of your screen to mute/unmute yourself and to enable/disable your video.